Eva Maria Fenyö
1 – 10 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent
(
- Contribution to journal › Article
-
Mark
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch
(
- Contribution to journal › Article
-
Mark
Frequent intratype neutralization by plasma immunoglobulin A identified in HIV-2 infection.
(
- Contribution to journal › Article
- 2012
-
Mark
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
(
- Contribution to journal › Article
-
Mark
Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1
(
- Contribution to journal › Article
-
Mark
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
(
- Contribution to journal › Article
- 2011
-
Mark
Reply to Redd et al
(
- Contribution to journal › Letter
-
Mark
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm
(
- Contribution to journal › Article
-
Mark
Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(
- Contribution to journal › Article